Healthy aging and medication management for World Trade Center responders
Promoting healthy aging and improving medication use in World Trade Center general responders
This project helps World Trade Center responders age well and manage their medications safely as they get older.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11162234 on NIH RePORTER |
What this research studies
As World Trade Center responders get older, many face health challenges like frailty and complex medication routines. This project aims to understand how best to offer healthy aging programs specifically tailored for this group. Researchers will look at a method called "deprescribing," which means carefully reducing or stopping medications that may no longer be needed or could cause harm. The goal is to make sure WTC responders receive the best possible care as they age.
Who could benefit from this research
Good fit: Ideal candidates are World Trade Center general responders who are aging and may be experiencing frailty or complex medication regimens.
Not a fit: Patients who are not World Trade Center responders or who are not experiencing aging-related health concerns may not directly benefit from this specific project.
Why it matters
Potential benefit: If successful, this work could lead to better health programs and safer medication practices for aging World Trade Center responders, improving their overall well-being.
How similar studies have performed: Previous work has identified frailty as a significant concern in this population, and this project builds on that understanding by exploring new intervention strategies.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Hung, William W.,mph, Md — Icahn School of Medicine at Mount Sinai
- Study coordinator: Hung, William W.,mph, Md
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.